[go: up one dir, main page]

MX2023003818A - Reprogramación, mantenimiento y conservación mejorados para células madre pluripotentes inducidas. - Google Patents

Reprogramación, mantenimiento y conservación mejorados para células madre pluripotentes inducidas.

Info

Publication number
MX2023003818A
MX2023003818A MX2023003818A MX2023003818A MX2023003818A MX 2023003818 A MX2023003818 A MX 2023003818A MX 2023003818 A MX2023003818 A MX 2023003818A MX 2023003818 A MX2023003818 A MX 2023003818A MX 2023003818 A MX2023003818 A MX 2023003818A
Authority
MX
Mexico
Prior art keywords
reprogramming
preservation
maintenance
stem cells
pluripotent stem
Prior art date
Application number
MX2023003818A
Other languages
English (en)
Inventor
Bahram Valamehr
Yi-Shin Lai
Ramzey Abujarour
Hui-Ting Hsu
Original Assignee
Fate Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Fate Therapeutics Inc filed Critical Fate Therapeutics Inc
Publication of MX2023003818A publication Critical patent/MX2023003818A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0696—Artificially induced pluripotent stem cells, e.g. iPS
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/48—Reproductive organs
    • A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
    • A61K35/545—Embryonic stem cells; Pluripotent stem cells; Induced pluripotent stem cells; Uncharacterised stem cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
    • C12N15/85—Vectors or expression systems specially adapted for eukaryotic hosts for animal cells
    • C12N15/86—Viral vectors
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/15—Transforming growth factor beta (TGF-β)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/10—Growth factors
    • C12N2501/16—Activin; Inhibin; Mullerian inhibiting substance
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/40—Regulators of development
    • C12N2501/415—Wnt; Frizzeled
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/70—Enzymes
    • C12N2501/72—Transferases [EC 2.]
    • C12N2501/727—Kinases (EC 2.7.)
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2501/00—Active agents used in cell culture processes, e.g. differentation
    • C12N2501/999—Small molecules not provided for elsewhere
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2506/00—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells
    • C12N2506/11—Differentiation of animal cells from one lineage to another; Differentiation of pluripotent cells from blood or immune system cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2510/00—Genetically modified cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2533/00—Supports or coatings for cell culture, characterised by material
    • C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16211—Lymphocryptovirus, e.g. human herpesvirus 4, Epstein-Barr Virus
    • C12N2710/16241—Use of virus, viral particle or viral elements as a vector
    • C12N2710/16243—Use of virus, viral particle or viral elements as a vector viral genome or elements thereof as genetic vector

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • Cell Biology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Reproductive Health (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Immunology (AREA)
  • Transplantation (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Plant Pathology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Materials For Medical Uses (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Se proporcionan métodos y composiciones para inducir la reprogramación de una célula no pluripotente usando un sistema vectorial soportado por moléculas pequeñas para proporcionar una iPSC que tenga las propiedades deseables con una alta eficiencia. También se proporcionan células de reprogramación y poblaciones de iPSC o líneas celulares clonales que usan los métodos y composiciones de reprogramación proporcionados. Además, se proporcionan composiciones y métodos para mantener y preservar las iPSC logrando al mismo tiempo la estabilidad genómica de las células.
MX2023003818A 2020-10-02 2021-10-01 Reprogramación, mantenimiento y conservación mejorados para células madre pluripotentes inducidas. MX2023003818A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US202063087119P 2020-10-02 2020-10-02
PCT/US2021/053240 WO2022072883A1 (en) 2020-10-02 2021-10-01 Improved reprogramming, maintenance and preservation for induced pluripotent stem cells

Publications (1)

Publication Number Publication Date
MX2023003818A true MX2023003818A (es) 2023-06-14

Family

ID=80950954

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2023003818A MX2023003818A (es) 2020-10-02 2021-10-01 Reprogramación, mantenimiento y conservación mejorados para células madre pluripotentes inducidas.

Country Status (10)

Country Link
US (1) US20240034999A1 (es)
EP (1) EP4222249A4 (es)
JP (1) JP2023544324A (es)
KR (1) KR20230078712A (es)
CN (1) CN116348592A (es)
AU (1) AU2021353586A1 (es)
CA (1) CA3193977A1 (es)
IL (1) IL301733A (es)
MX (1) MX2023003818A (es)
WO (1) WO2022072883A1 (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024020587A2 (en) 2022-07-22 2024-01-25 Tome Biosciences, Inc. Pleiopluripotent stem cell programmable gene insertion
WO2024078119A1 (en) * 2022-10-12 2024-04-18 Peking University Methods for chemical reprogramming and pluripotent stem cells

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA3194845A1 (en) * 2009-10-16 2011-04-21 The Scripps Research Institute Induction of pluripotent cells
US9732319B2 (en) * 2010-12-22 2017-08-15 Fate Therapeutics, Inc. Cell culture platform for single cell sorting and enhanced reprogramming of iPSCs
WO2014165663A1 (en) * 2013-04-03 2014-10-09 Cellular Dynamics International, Inc. Methods and compositions for culturing endoderm progenitor cells in suspension
KR102460549B1 (ko) * 2014-03-04 2022-10-28 페이트 세러퓨틱스, 인코포레이티드 개선된 재프로그래밍 방법 및 세포 배양 플랫폼
WO2017123789A1 (en) * 2016-01-12 2017-07-20 Lonza Walkersville, Inc. Methods and vectors to produce vector free induced pluripotent stem cells
KR102786649B1 (ko) * 2017-10-11 2025-03-25 페이트 세러퓨틱스, 인코포레이티드 시간적 및 일시적 플라스미드 벡터 발현 시스템을 사용한 세포 재프로그래밍

Also Published As

Publication number Publication date
WO2022072883A1 (en) 2022-04-07
CA3193977A1 (en) 2022-04-07
US20240034999A1 (en) 2024-02-01
JP2023544324A (ja) 2023-10-23
EP4222249A1 (en) 2023-08-09
AU2021353586A1 (en) 2023-05-11
KR20230078712A (ko) 2023-06-02
EP4222249A4 (en) 2025-02-26
CN116348592A (zh) 2023-06-27
AU2021353586A9 (en) 2024-09-26
IL301733A (en) 2023-05-01

Similar Documents

Publication Publication Date Title
MX2023003818A (es) Reprogramación, mantenimiento y conservación mejorados para células madre pluripotentes inducidas.
MX2013006958A (es) Medio del cultivo celular.
AU2018260810A1 (en) Defined media for expansion and maintenance of pluripotent stem cells
BR112016026626A2 (pt) Uso de moléculas pequenas para melhorar a expressão de mafa em células pancreáticas endócrinas
MX2021005625A (es) Metodos para aislar, cultivar y dise?ar geneticamente poblaciones de celulas inmunes para terapia adoptiva.
BR112021015887A8 (pt) Método para criopreservação de célula-tronco, população de células-tronco, composição de criopreservação, uso de nac, e kit de criopreservação
GB2432846B (en) Medium and culture of embryonic stem cells
MX382080B (es) Método para cultivar células eucariónticas.
MX2014009306A (es) Metodo sin alimentadoras para cultivo de celulas madre espermatogonias de bovino y porcino.
EP4368701A3 (en) Feeder-free culture system
WO2012032521A3 (en) Novel methods and culture media for culturing pluripotent stem cells
MX2020003739A (es) Reprogramacion celular mediante el uso de un sistema de expresion de vector plasmidico temporal y transitorio.
MX2023007466A (es) Composiciones y métodos para reducir los hla-a en una célula.
SG11201809400UA (en) Purification method for pancreatic precursor cells derived from pluripotent stem cells and amplification method therefor
MY199544A (en) Method for preserving neural tissue
NZ744832A (en) Nanos2 knock-out that ablates germline cells
BR112021023554A2 (pt) Composições e métodos para cultura de células vegetais
EP4240346A4 (en) PROCEDURES FOR ALLOGENEOUS TRANSPLANTATION OF HEMATOPOETIC STEM CELLS
BR112022018640A2 (pt) Métodos para produzir uma população de células compreendendo cardiomiócitos e para purificar cardiomiócitos, população de células contendo cardiomiócitos, e, agente para terapia de transplante de células
AU2019356414A8 (en) Binding proteins specific for HA-1H and uses thereof
ZA202307198B (en) Lyophilized mesenchymal stem cells
MX2023008055A (es) Métodos para inducir tolerancia inmune con anticuerpos anti-cd154 modificados.
BR112022024866A2 (pt) Cultura 3d de células precursoras da linhagem mesenquimal ou células-tronco
WO2023064284A9 (en) Derivation of hepatocytes and hematopoietic progenitors from human embryonic stem cells
AR118480A1 (es) Métodos para mejorar la biomasa en una planta mediante la estimulación de la regeneración de rubp y el transporte de electrones